Core Insights - During market turbulence, investors often seek dividend-yielding stocks, which typically have high free cash flows and offer substantial dividends [1] Group 1: Perrigo Company PLC (NYSE:PRGO) - Dividend Yield: 8.83% [6] - Canaccord Genuity analyst Susan Anderson maintained a Buy rating but reduced the price target from $40 to $20 on Nov. 6, 2025, with an accuracy rate of 62% [6] - JP Morgan analyst Chris Scott downgraded the stock from Overweight to Neutral, cutting the price target from $32 to $20 on Nov. 6, 2025, with an accuracy rate of 65% [6] - Recent News: Perrigo reported mixed Q3 financial results and lowered its FY25 adjusted EPS guidance below estimates [6] Group 2: Bristol-Myers Squibb Co (NYSE:BMY) - Dividend Yield: 4.81% [6] - Morgan Stanley analyst Terence Flynn maintained an Underweight rating and reduced the price target from $37 to $36 on Dec. 12, 2025, with an accuracy rate of 69% [6] - Guggenheim analyst Seamus Fernandez upgraded the stock from Neutral to Buy, setting a price target of $62 on Dec. 12, 2025, with an accuracy rate of 81% [6] - Recent News: Bristol Myers Squibb received FDA Priority Review for Opdivo Plus AVD combination sBLA in untreated stage III/IV cHL [6] Group 3: CVS Health Corp (NYSE:CVS) - Dividend Yield: 3.35% [6] - Truist Securities analyst David Macdonald maintained a Buy rating and raised the price target from $95 to $98 on Dec. 10, 2025, with an accuracy rate of 67% [6] - UBS analyst Kevin Caliendo maintained a Buy rating and increased the price target from $96 to $97 on Dec. 10, 2025, with an accuracy rate of 65% [6] - Recent News: CVS raised its FY2025 adjusted EPS and sales guidance [6]